Biotechspert

Biotechspert is developing a freelance consultancy platform that seeks to instantly connect businesses with leading experts in the bioscience sector, driving innovation, growth and investment. Biotechspert completed its funding round on SyndicateRoom in September 2017, raising £236,099.

The story

Biotechspert is an analytics platform that facilitates access to specialist technical, scientific and commercial expertise on a global scale. Biotechspert has developed algorithms to identify, map and rank experts in very specific market niches. For instance, a VC associate in need of quickly speaking to some key opinion leaders regarding a new pathway in cystic fibrosis may choose to pay Biotechspert to identify the leading experts in this field and connect with them over the phone.

The team

Biotechspert was founded by COO Graham Mills and CEO David Holden-White, because they both felt there was a significant challenge with accessing specialist expertise in the sector from investor and SME perspectives.

Since graduating from Oxford with a First Class Master's in Biochemistry, David has continued to work in the field of biotech innovation. He spent two years at Carpmaels and Ransford as a Patent Attorney specialising in biotechnology, gaining intellectual property certification from Queen Mary’s University. He subsequently moved to Cambridge and completed the Bioscience Enterprise Master's. David has worked in corporate development for Psyomics, a Cambridge-based diagnostics company, helping it grow from pre-seed through to Series A. Since April 2017 he has been dedicated full-time to Biotechspert.

The lead investor

Zack Feather founded Asclepius Global, a healthcare staffing and IT consultancy, in 2006. The company grew rapidly to achieve revenues in excess of £60m in 2013, when it was acquired by private equity firm Blackstone. Zack is a global leader in the healthcare recruitment and analytics field and currently sits on the board of five companies in the sector including Coben Medical, Draper and Dash, and Umed.

Staying ahead in the rapidly evolving healthcare and life sciences sector requires rapid access to the world-leading scientific, technical and clinical specialists, in precisely the required niche… current solutions are longwinded and labour intensive.

Zack Feather

Biotechspert lead investor

See current opportunities

Celame

EIS
Legaltech & Regtech
Celame, a website aiming to improve transparency and accessibility in the legal sector for consumers and SMEs, successfully raised finance on SyndicateRoom.

Active

Trading status

£24,950

Average investment

£748,509

Total raised

Brytlyt

EIS
Software & Computer Services
Brytlyt, a company creating a radically new approach to the underlying hardware for data processing, twice raised capital on SyndicateRoom. Read more here.

Active

Trading status

£9,961

Average investment

£473,400

Total raised

Articheck

EIS
Software & Computer Services
Articheck is an SaaS company which create passports for works-of-art to accompany them on their travels. The company raised funds on SyndicateRoom in 2017.

Active

Trading status

£12,624

Average investment

£618,571

Total raised

Redecol

EIS
Medtech
Redecol, a company developing an asthma monitoring device to address the need for a new lung function test, succesfully raised funds on SyndicateRoom.

Active

Trading status

£8,545

Average investment

£555,438

Total raised

Dymag

EIS
Engineering & Manufacturing
Dymag has twice raised funds on SyndicateRoom. The company designs and manufactures high-performance carbon composite car and motorcycle wheels.

Active

Trading status

£13,513

Average investment

£499,998

Total raised

Re-Vana Therapeutics

EIS
Pharmaceuticals & Biotechnology
Re-Vana Therapeutics is a life science spin-out from Queen’s University Belfast. The company raised £1,104,593 on SyndicateRoom in September 2017.

Active

Trading status

£19,725

Average investment

£1,104,593

Total raised